Tirzepatide, a recently approved medication, is creating considerable interest within the medical community. It operates differently from existing diabetes therapies , targeting two receptors involved in glucose regulation and satiety. Initial research have demonstrated impressive efficacy in lowering blood sugar in individuals with adult-onset dia